EHSI.US Elite Health Systems Inc.
- Market cap
- USD 23.7M
- P/E
- -
- P/B
- 9.21x
- ROE
- -220.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is EHSI.US undervalued?
Graham numberThe Graham number of Elite Health Systems Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Elite Health Systems Inc. fundamental analysis
No fundamental analysis for Elite Health Systems Inc. yet.
Elite Health Systems Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Elite Health Systems Inc.
Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and other healthcare related services in California and Nevada. The company also focuses on improving and providing access to healthcare, primarily for seniors and special needs groups. The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 a…
Full company profileElite Health Systems Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Elite Health Systems Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2009 | 2010 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 41.8K | 0.00 | 14.0K | 1.06M | 0.00 | 0.00 | 0.00 | 1.02M | 5.42M |
| Gross Profit | 41.8K | 0.00 | 14.0K | 975K | 0.00 | - | 0.00 | 118K | 570K |
| Operating Income | -244K | -40.0K | -504K | -88.0K | -1.39M | -765K | -1.79M | -3.84M | -5.68M |
| EBITDA | - | - | - | - | -1.49M | -794K | -1.78M | -3.80M | -5.50M |
| Net Income | 64.9K | -3.65M | -518K | -881K | -1.34M | -816K | -2.06M | -7.80M | -5.65M |
| EPS | - | - | - | -0.11 | -0.17 | -0.09 | -0.10 | -0.27 | -0.20 |
| Balance Sheet | |||||||||
| Total Assets | 2.37M | 1.60K | 2.27M | 3.69M | 1.75M | 1.32M | 4.32M | 6.66M | 3.92M |
| Total Liabilities | 2.26M | 376K | 1.12M | 660K | 291K | 676K | 143K | 1.35M | 1.35M |
| Shareholders' Equity | 109K | -374K | 1.15M | 2.58M | 1.24M | 645K | 4.18M | 5.31M | 2.57M |
| Cash & Short-term Investments | 546K | - | 9.81K | 2.18M | 1.54M | 466K | 4.03M | 3.76M | 1.30M |
| Cash Flow | |||||||||
| Operating Cash Flow | -260K | -30.4K | -495K | 174K | -1.41M | -891K | -1.52M | -2.94M | -5.22M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.08M | 0.00 |
| Free Cash Flow | - | - | - | 174K | -1.41M | -891K | -1.52M | -4.02M | -5.22M |
| Ratios | |||||||||
| ROE | 59.3% | - | -44.9% | -34.2% | -107.9% | -126.5% | -49.2% | -146.9% | -220.0% |
| ROA | 2.7% | -227,871.2% | -22.8% | -23.9% | -76.5% | -61.8% | -47.6% | -117.1% | -144.3% |
| Net Profit Margin | 155.2% | - | -3,691.2% | -83.0% | - | - | - | -762.1% | -104.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Elite Health Systems Inc. dividends
Elite Health Systems Inc. has not paid dividends in the last 8 fiscal years.
Who owns Elite Health Systems Inc.
- Insiders 26.71%
- Institutions 5.53%
- Public & others 67.75%
- Shares outstanding 28.5M
- Free float 22.1M
Elite Health Systems Inc. company profile
- Company name
- Elite Health Systems Inc.
- Ticker
- EHSI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 87
- Fiscal year end
- December
- Address
- 1131 W 6th Street, Ontario, CA, United States, 91762
- Phone
- 949 249 1170
About Elite Health Systems Inc.
Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and other healthcare related services in California and Nevada. The company also focuses on improving and providing access to healthcare, primarily for seniors and special needs groups. The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 and is headquartered in Ontario, California.
Elite Health Systems Inc. management
2- Dr. Jeereddi Anjaneya Prasad M.D.CEO, President & Chairman · born 1948
- Mr. Kenneth A. Minor CPACFO & Secretary · born 1962